Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study
Titel:
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study
Auteur:
Fuereder, Thorsten Minichsdorfer, Christoph Mittlboeck, Martina Wagner, Christina Heller, Gerwin Putz, Eva M. Oberndorfer, Felicitas Müllauer, Leonhard Aretin, Marie-Bernadette Czerny, Christian Schwarz-Nemec, Ursula